New hope for diabetic nerve pain: mirogabalin trial launches
NCT ID NCT07451431
First seen Mar 16, 2026 · Last updated May 25, 2026 · Updated 9 times
Summary
This study tests whether the drug mirogabalin can reduce nerve pain and improve quality of life in adults with diabetic peripheral neuropathy. About 78 participants will take either mirogabalin or the standard drug pregabalin daily for 8 weeks. The goal is to see if mirogabalin is safer and more effective at easing pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bangladesh Medical University
RECRUITINGDhaka, 1000, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.